---
title: "1,207 Healthtech Investors (Nov 2026): Top 10 by Fund Activity"
last_updated: "2026-11-09"
rows: "1207"
free_rows: "25"
source: "SEC Form D filings and our own research"
canonical: "https://theinvestordatabase.com/lists/healthtech-investors/"
---

# 1,207 healthtech investors

We list 1,207 healthtech investors as of November 2026: 720 have an SEC filing on file and 487 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The states with the most are California (240), New York (100) and Massachusetts (58).

- 1,207 investors
- 560 with a fund filing or dated deal in the last 12 months
- $60M median fund size on file (SEC Form D, 514 firms)
- 5,558 named decision-makers on file

## First 25 of 1,207 healthtech investors

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Innovation Industries | VC firm | Amsterdam, Netherlands | Series A, Series B, Growth | Healthtech, Deep Tech, AI, Food and Beverage | New fund, Oct 2026 | €1.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/innovation-industries-capital-partners-b-v/ |
| PXN Ventures | Fund manager | Manchester, United Kingdom | Pre-seed, Seed, Series A, Growth | Healthtech, Generalist, SaaS, Deep Tech | Portfolio news, Nov 2026 | £760M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/pxn-ventures/ |
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Healthtech, Edtech, Developer Tools, Mobility | Portfolio news, Oct 2026 | £3.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/bgf/ |
| Bullhound Capital | VC firm | London, United Kingdom | Growth | Healthtech, AI, Quantum, Robotics | New deal, Oct 2026 | €1.0B (own site) | 2026-11-05 | https://theinvestordatabase.com/investors/bullhound-capital/ |
| Cathay Innovation | VC firm | Paris, France | Seed, Series A, Series B, Growth, Late stage | Healthtech, AI, Robotics, Fintech | Portfolio news, Aug 2026 | €2.5B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/cathay-innovation/ |
| Claret Capital Partners | Venture debt | London, United Kingdom | Series B, Growth, Late stage | Healthtech, Biotech, Climate Tech, SaaS | New deal, Oct 2026 | €575M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/claret-capital-partners/ |
| Electric Capital | VC firm | Palo Alto, CA | Pre-seed, Seed, Series A | Healthtech, Crypto and Web3, AI, Fintech | New fund, Sep 2026 | $532M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/electric-capital/ |
| Salica Investments | Fund manager | London, United Kingdom | Seed, Series A, Growth | Healthtech, Fintech, AI, Climate Tech | Portfolio news, Oct 2026 | £760M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/salica/ |
| Balderton Capital | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Healthtech, AI, Fintech, Developer Tools | Portfolio news, Oct 2026 | $5.7B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/balderton-capital/ |
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Healthtech, Biotech, Medtech | Portfolio news, Oct 2026 | $2.8B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hbm-partners-ag/ |
| Khosla Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Growth | Healthtech, AI, Consumer, B2B | New fund, Aug 2026 | $1.9B (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/khosla-ventures/ |
| Lux Ventures | VC firm | New York, NY |  | Healthtech, AI, Mobility, Media | New fund, Sep 2026 | $1.5B (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/lux-ventures/ |
| NSV | VC firm | Greenwich, CT | Seed, Late stage | Healthtech, AI, Semiconductor, Mobility | Portfolio news, Oct 2026 | $990M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/nsv/ |
| Felicis | VC firm | Menlo Park, CA | Seed, Series A | Healthtech, AI, Developer Tools, Cybersecurity | New deal, Oct 2026 | $900M (SEC Form D, 2025) | 2026-11-05 | https://theinvestordatabase.com/investors/felicis/ |
| Digitalis Ventures | VC firm | New York, NY | Seed | Healthtech, Biotech, Medtech | Portfolio news, Nov 2026 | $862M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/digitalis-ventures/ |
| Cambridge Innovation Capital | VC firm | Cambridge, United Kingdom | Seed, Series A, Growth | Healthtech, Biotech, AI, Fintech | New fund, Oct 2026 | £600M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/cambridge-innovation-capital/ |
| Menlo Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Series B, Growth | Healthtech, AI, Media, Robotics | New fund, Sep 2026 | $800M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/menlo-ventures/ |
| Transformation Capital | VC firm | Boston, MA | Growth | Healthtech, Medtech | New fund, Sep 2026 | $800M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/transformation-capital/ |
| Mercia Asset Management | Fund manager | Henley-in-Arden, United Kingdom | Seed, Series A, Growth | Healthtech, Future of Work, AI, SaaS | Portfolio news, Oct 2026 | £400M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/mercia/ |
| The FSE Group | Fund manager | Fleet, United Kingdom | Seed, Series A, Growth | Healthtech, Generalist, Climate Tech, SaaS | Portfolio news, Sep 2026 | £395M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/the-fse-group/ |
| Vida Ventures | VC firm | Los Angeles, CA |  | Healthtech, Biotech | New fund, Sep 2026 | $750M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/vida-ventures/ |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Healthtech, Biotech, Medtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/andera-partners/ |
| ARCH Venture Partners | VC firm | Chicago, IL | Pre-seed, Seed | Healthtech, Biotech, Deep Tech | New fund, Aug 2026 | $3.0B (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/arch-venture-partners/ |
| New Science Ventures | VC firm | United States | Seed, Growth, Late stage | Healthtech, Deep Tech, AI, Semiconductor | Portfolio news, Oct 2026 | $1.0B (own site) | 2026-11-05 | https://theinvestordatabase.com/investors/new-science-ventures/ |
| OneTarget | VC firm | Berlin, Germany | Seed, Series A, Series B, Growth | Healthtech, AI, Fintech, Consumer | Portfolio news, Sep 2026 | $3.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/onetarget/ |

You are seeing 25 of 1,207. The full list adds 1,182 more investors and 5,558 named decision-makers.

Get all 1,207 investors and 5,558 named contacts, $297, one-time: https://theinvestordatabase.com/buy/bundle
This page: https://theinvestordatabase.com/lists/healthtech-investors/

## Method and limits
- Source: 720 of the 1,207 rows carry an SEC filing (Form D or Form ADV). 1,205 of the 1,207 have a website we checked; the other 2 rest on the filing or register entry alone. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states healthtech and digital health as a focus on its own site, or we observed it in the firm's portfolio.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (40: within 3 months 40, 6 months 30, 12 months 20, 24 months 10), share of the observed portfolio in this sector (30; 15 when the sector is stated only), size of the fund on file on a log scale (20) and completeness of the public record (10). It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 1,207 rows: stage 1,043, sector 1,207, fund size 838, website 1,205. In the paid file: named decision-makers on 1,104 rows, firm email on 558, LinkedIn page on 752, check size on 266.

## Questions
### How many healthtech investors are there?
We list 1,207 as of November 2026. 560 of the 1,207 have a fund filing or a dated deal in the last 12 months. By region: United States (720), United Kingdom (194) and Europe (291).

### Which healthtech investors raised a new fund in the last 12 months?
282 of the 1,207 have a fund filing dated in the last 12 months. The most recent on this list are Quiet Capital (Nov 2026), Branch Venture Partners (Nov 2026) and LightX Capital (Nov 2026).

### What is the typical fund size of healthtech investors?
The median fund size on file for this list is $60M, across the 514 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 693 do not disclose a size there.

### Which stage do most healthtech investors back?
Of the 1,043 with a stage on file, seed (800), pre-seed (408) and Series A (401). A firm can back more than one stage, and 164 rows have no stage on file yet.

### Where does the data on healthtech investors come from and how often is it updated?
720 of the 1,207 rows have an SEC filing on file (Form D or Form ADV) and 487 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.

### Can I download the list of healthtech investors as a spreadsheet?
Yes. The file holds all 1,207 rows in Excel and CSV, with 5,558 named decision-makers and 558 firm emails, for $297 one-time as part of Global Bundle. 25 rows are free on this page.